Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Francesc Cobo Valien
27 years of experience
Clinic is certified :
Leukemia treatment cost in Spain typically starts with a bone marrow biopsy, which ranges from $500 to $1,400, while primary leukemia chemotherapy runs from $20,000 to $40,000. Expenses depend on the leukemia subtype, treatment cycles, and the choice between standard or advanced protocols like CAR T-cell therapy. Patients can expect 40-60% savings compared to the US. Leading medical hubs for hematology include Barcelona, Madrid, and Pamplona.
Typical Leukemia Treatment Costs in Spain
Bookimed Expert Insight: Pediatric patients require specialized molecular diagnostics found at SJD Barcelona Children's Hospital. It ranks as a top-3 European institution for children's oncology. For complex adult cases, Clinica Universidad de Navarra offers advanced onco-hematology with JCI accreditation. Patients seeking research-driven care should consider Quironsalud Madrid. It provides unique clinical trial participation opportunities for neurodegenerative and cancer disorders. Centro Médico Teknon remains a preferred choice for high-profile patients. It features elite specialists like Dr. Francesc Cobo Valien with 25 years of experience.
| Turkey | Austria | Spain | |
| Chemotherapy for breast cancer | from $1,200 | from $15,000 | from $3,500 |
| CAR T-cell therapy | from $150,000 | from $350,000 | from $330,000 |
| Leukemia chemotherapy | from $8,000 | from $15,000 | from $20,000 |
| Therapeutic Apheresis | from $1,350 | - | - |
Specialist in bone marrow transplantation – Dr. Rives Sola focuses on pediatric hematology at SJD Barcelona Children's Hospital.
Award-winning pediatric oncologist specializing in childhood cancers – heads Hematology Oncology at SJD Barcelona Children's Hospital, ranked among Europe's best.
Dr. Cobo Valien leads the Hematologic Malignancies Unit at Centro Médico Teknon, specializing in leukemia with over 1,100 treatments performed.
Prof. Bosch leads global research in Chronic Lymphocytic Leukemia (CLL), with 80+ active clinical trials advancing new treatments.
Written by Anna Leonova
Spain is a leading global destination for CAR T-cell therapy. The country offers both commercial products and unique academic versions developed in hospitals. Specialist centers in Barcelona and Madrid provide these treatments for relapsed or refractory leukemia, lymphoma, and multiple myeloma.
Bookimed Expert Insight: Spain is unique because its hospitals develop their own CAR-T treatments under a special exemption. This allows academic centers like Hospital Clínic de Barcelona to offer therapy for approximately $90,000. This is significantly more affordable than commercial products that can exceed $350,000. For international patients, choosing an academic protocol in Barcelona can save over $200,000 while maintaining high safety standards.
Patient Consensus: Patients note that while the public system is excellent, the bureaucratic approval process for therapy can take 3 to 9 months. Many recommend consulting a specialist early to navigate regional differences and secure a slot in Madrid or Barcelona hospitals.
Spain is a global leader in leukemia treatment. Major centers in Barcelona and Madrid provide specialized therapies like CAR T-cell and bone marrow transplants. Facilities like Centro Médico Teknon and SJD Barcelona Children's Hospital hold prestigious Joint Commission International accreditation for oncology and hematology care.
Bookimed Expert Insight: Spanish oncology centers offer a rare combination of private comfort and heavy academic research. Clinica Universidad de Navarra serves over 700,000 patients from 70 countries. It was the first hospital in Spain to earn Joint Commission International accreditation. This reflects a long-standing commitment to safety and protocol that newer centers are still building.
Patient Consensus: Patients highlight that translators at centers like Centro Médico Teknon make the experience smooth. They often express relief at how clearly doctors explain subsequent medication phases.
International patients can join leukemia clinical trials in Spain. Participation depends on trial-specific inclusion criteria and sponsor approval. While enrollment is possible for early-phase studies, non-EU residents often require private funding for standard medical care. Specialized academic centers in Madrid and Barcelona currently lead these initiatives.
Bookimed Expert Insight: Quironsalud Madrid provides rare opportunities for free leukemia treatment within clinical trials if specific requirements are met. Our data shows that high-volume centers like Clínica Universidad de Navarra, which serves 700,000 patients from 70 countries, have more robust infrastructure for managing international trial participants compared to smaller regional clinics.
Patient Consensus: Patients note that Phase I and II studies in Spain often prioritize EU citizens due to funding rules. They suggest preparing private insurance and proof of self-funding early to avoid long enrollment delays.
Travel to Spain for leukemia therapy without prior authorization depends on your nationality and funding. EU citizens require an S2 form for public healthcare coverage. Private patients do not need state authorization but must secure a medical invitation from clinics like Centro Médico Teknon or Quironsalud Madrid.
Bookimed Expert Insight: Spain is a top-3 global destination on Bookimed, and the data reveals a heavy focus on high-volume centers in Barcelona and Madrid. While many look for general oncology, patients should target specific experts like Dr. Francesc Cobo Valien at Centro Médico Teknon or Dr. Francesc Bosch at Hospital Quiron Barcelona. These specialists have performed thousands of procedures and lead clinical trials, providing access to therapies often unavailable in smaller regional hospitals.
Patient Consensus: Patients note that traveling with a translator makes the experience much smoother. They also emphasize carrying a formal hospital invitation letter to avoid issues with immigration officials when entering Spain.
Barcelona and Madrid are Spain's primary hubs for leukemia specialists. Barcelona leads in pediatric care and research. Madrid offers the largest private bone marrow transplant programs. Pamplona remains a critical center due to the global reputation of Clínica Universidad de Navarra for hematology.
Bookimed Expert Insight: Barcelona clinics often serve as a bridge for advanced American protocols. Dr. Jaume Mora Graupera at SJD participated in fellowships at Memorial Sloan Kettering. This transatlantic connection brings US molecular pathology standards directly to Spanish hematology departments. It is a major reason why international patients favor Barcelona for pediatric leukemia.
Patient Consensus: Patients note that while Madrid and Barcelona offer the most specialists, the public centers like Vall d'Hebron are highly recommended. They often suggest confirming recent research breakthroughs for specific leukemia types before choosing a facility.
Spanish hospitals manage language barriers for leukemia patients through on-site certified translators and multilingual medical coordinators. Facilities utilize 24/7 remote interpretation for 180 languages to ensure accuracy. Leading centers provide dedicated international departments. These teams handle clinical documentation and treatment planning in the patient preferred language.
Bookimed Expert Insight: While many think only private clinics provide language support, leading institutions like Centro Médico Teknon or Clinica Universidad de Navarra maintain dedicated international departments that function as full-service communication hubs. Our data shows these coordinators handle everything from initial scans to complex follow-ups. This is why these hospitals consistently earn higher patient satisfaction ratings. Selecting a clinic with an established international department is often more effective than relying on translation apps alone.
Patient Consensus: Patients note that having a professional translator makes the entire medical experience smooth and easy to manage. They strongly advise booking interpreters through the international office specifically for consent forms and diagnostic test results.
Discuss the specific leukemia subtype and genetic markers like FLT3 during your first consultation. Inquire about cytogenetics and molecular testing to guide treatment. Ask about the multidisciplinary team and clinical trial eligibility available at Spanish centers like Quironsalud Madrid.
Bookimed Expert Insight: Spanish oncology centers like Clinica Universidad de Navarra maintain exceptional quality standards. This center reached a 95% rate of affected limb preservation in sarcoma. For leukemia patients, this indicates a deep focus on long-term functional survival. Seek clinics with JCI and ESMO accreditations to ensure high-level evidence-based care.
Patient Consensus: Patients note it is important to confirm wait times for cytogenetics. They also suggest requesting a translator to ensure every medical detail is clear.